FDA liver risk warning for Bristol-Myers HIV drug

February 1, 2010

(AP) -- Federal health officials say patients taking a Bristol-Myers Squibb drug for HIV have reported a rare, but potentially fatal liver disorder.

The says it received 42 reports of the disorder since Videx was approved in 1991. Four patients died from bleeding or liver failure after developing the problem, known as non-cirrhotic portal .

The problem involves dangerously slow blood flow though the liver, which can cause veins in the esophagus to swell. These veins are thin and can cause burst, causing potentially deadly bleeding.

FDA says it is keeping the drug on the market because its benefits outweigh its risks. The agency added warnings to the drug's label about the signs of the liver disorder.

shares

Related Stories

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.